BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Apoptosis
,
Obesity
,
Heart
,
Human chorionic gonadotropin
,
Lipopolysaccharide
,
FGF21
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
stat3 protein, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Cooperative Signaling in the STAT3 and NF-kB Pathways in Subtypes of diffuse large B cell lymphoma
Embryonic stem cell lines expressing hormone-dependent STAT3-ERT2 treated with LIF and 2i inhibitors
Dendritic cells with STAT3 mutation treated with LPS followed by IL10 or IL6 treatment
Lung cancer A549 cells overexpressing PIAS3 or depleted of STAT3
B cells from autosomal dominant hyper IgE syndrome patients cultured with CD40L and IL21
Explore Curated Studies Results
Literature
Most Relevant Literature
Germline Mosaicism in STAT3: A Pitfall for Genetic Diagnosis, Counseling, and Therapy of Hyper-IgE S…
Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery.
Obstructive uropathy in STAT 3 hyper immunoglobulin E syndrome: A 5 year old Middle Eastern boy.
Dissecting Out a Rare Mutation, STAT: Features of STAT3-Mutant Myeloid Neoplasms.
A challenging differential diagnosis in a patient with autosomal dominant STAT3 deficiency.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers
AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites
STAT3 Inhibitor for Solid Tumors
In Vivo Leptin Signaling in Humans After Acute Leptin Administration
Immunology Dysregulation in Lymphadenitis Tuberculosis : An Observational Study Using Patient' Block…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ